Recent patents on implantable drug/protein delivery systems fabricated using electrospinning

Recent Patents on Biomedical Engineering

Volumn 5, Issue 1, 2012, Pages 14-22

  Xu, Weijie ^a   Lee, Sang Jin ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Drug delivery system; Electrospinning; Medical device; Scaffold; Tissue engineering

Indexed keywords

ANIMAL EXPERIMENTS; BIOACTIVE MOLECULES; CELLULAR INTERACTION; CLINICAL TRANSLATION; COAXIAL ELECTROSPINNING; CONTROLLED RELEASE; DAMAGING EFFECTS; DELIVERY SYSTEMS; DELIVERY VEHICLE; DRUG DELIVERY SYSTEM; ELECTROSPINNING TECHNIQUES; ELECTROSPUN FIBERS; ELECTROSPUNS; EXTRACELLULAR MATRICES; FIBROUS STRUCTURES; HIGH SURFACE AREA; IN-VITRO; IN-VIVO; INTERCONNECTIVITY; MEDICAL DEVICES; NATURAL MATERIALS; STRUCTURAL MORPHOLOGY; SURFACE IMMOBILIZATION; SYNTHETIC POLYMERS; TISSUE-ENGINEERED SCAFFOLDS; VOLUME RATIO; WOUND HEALING APPLICATIONS;

BIOACTIVITY; BIOCOMPATIBILITY; BIOMEDICAL EQUIPMENT; DRUG DELIVERY; EMULSIFICATION; NATURAL POLYMERS; ORGANIC SOLVENTS; PATENTS AND INVENTIONS; SCAFFOLDS; SCAFFOLDS (BIOLOGY); TISSUE; TISSUE ENGINEERING;

ELECTROSPINNING;

ANIMALIA;

EID: 84860300315     PISSN: 18747647     EISSN: None     Source Type: Journal    
DOI: 10.2174/1874764711205010014     Document Type: Article

References (65)

1. Laurencin CT, Kumbar SG, Nukavarapu SP, et al. Recent Patents on Electrospun Biomedical Nanostructures: An Overview. Recent Patents on Biomedical Engineering 2008; 1: 68-78.
2. He W, Ma Z, Teo WE, et al. Tubular nanofiber scaffolds for tissue engineered small-diameter vascular grafts. J Biomed Mater Res A 2009; 90: 205-16.
3. He W, Yong T, Teo WE, et al. Fabrication and endothelialization of collagen-blended biodegradable polymer nanofibers: potential vascular graft for blood vessel tissue engineering. Tissue Eng 2005; 11: 1574-88.
4. Ju YM, Choi JS, Atala A, et al. Bilayered scaffold for engineering cellularized blood vessels. Biomaterials 2010; 31: 4313-21.
5. Lee SJ, Liu J, Oh SH, et al. Development of a composite vascular scaffolding system that withstands physiological vascular conditions. Biomaterials 2008; 29: 2891-8.
6. Lee SJ, Yoo JJ, Lim GJ, Atala A, Stitzel J. In vitro evaluation of electrospun nanofiber scaffolds for vascular graft application. J Biomed Mater Res A 2007; 83: 999-1008.
7. Burger C, Hsiao B, Chu B. Nanofibrous Materials and Their Applications. Annu Rev Mater Res 2006; 36: 333-68.
8. Asakura T, Adachi K, Schwartz E, Stabilizing effect of various organic solvents on proteins. J Biol Chem 1978; 253: 6423-5.
9. Kriegel C, Kit K, McClements D, et al. Nanofibers as carrier systems for antimicrobial microemulsions. Part I: fabrication and characterization. Langmuir 2009; 25: 1154-61.
10. Li X, Su Y, He C, et al. Sorbitan monooleate and poly(L-lactideco-epsilon-caprolactone) electrospun nanofibers for endothelial cell interactions. J Biomed Mater Res A 2009; 91: 878-85.
11. Li X, Su Y, Liu S, et al. Encapsulation of proteins in poly(Llactide-co-caprolactone) fibers by emulsion electrospinning. Colloids Surf B Biointerfaces 2010; 75: 418-24.
12. Li X, Su Y, Zhou X, et al. Distribution of Sorbitan Monooleate in poly(L-lactide-co-epsilon-caprolactone) nanofibers from emulsion electrospinning. Colloids Surf B Biointerfaces 2009; 69: 221-4.
13. Liu S, Su Y, Chen Y. Fabrication, Surface Properties and Protein Encapsulation/Release Studies of Electrospun Gelatin Nanofibers. J Biomater Sci Polym Ed 2011; 22: 945-55.
14. Qi H, Hu P, Xu J, et al. Encapsulation of drug reservoirs in fibers by emulsion electrospinning: morphology characterization and preliminary release assessment. Biomacromolecules 2006; 7: 2327-30.
15. Qiu X, Dong N, Sun Z, et al. Controlled release of siRNA nanoparticles loaded in a novel external stent prepared by emulsion electrospinning attenuates neointima hyperplasia in vein grafts. Zhonghua Yi Xue Za Zhi 2009; 89: 2938-42.
16. Xu X, Chen X, Ma P, et al. The release behavior of doxorubicin hydrochloride from medicated fibers prepared by emulsionelectrospinning. Eur J Pharm Biopharm 2008; 70: 165-70.
17. Xu X, Chen X, Wang Z, et al. Ultrafine PEG-PLA fibers loaded with both paclitaxel and doxorubicin hydrochloride and their in vitro cytotoxicity. Eur J Pharm Biopharm 2009; 72: 18-25.
18. Yan S, Xiaoqiang L, Shuiping L, et al. Controlled release of dual drugs from emulsion electrospun nanofibrous mats. Colloids Surf B Biointerfaces 2009; 73: 376-81.
19. Liao I, Chew S, Leong K. Aligned core-shell nanofibers delivering bioactive proteins. Nanomedicine 2006; 1: 465-71.
20. Liao I, Chen S, Liu J, et al. Sustained viral gene delivery through core-shell fibers. J Control Release 2009; 139: 48-55.
21. Huang Z, He C, Yang A, et al. Encapsulating drugs in biodegradable ultrafine fibers through co-axial electrospinning. J Biomed Mater Res A 2006; 77: 169-79.
22. Chew S, Wen J, Yim E, et al. Sustained release of proteins from electrospun biodegradable fibers. Biomacromolecules 2005; 6: 2017-24.
23. Luu, YK, Kim K, Hsiao BS, et al. Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA-PEG blokc copolymers. J Control Release 2003; 89: 341-53.
24. Kim K, Luu YK, Chang C, et al. Incorporation and controlled release of a hydrophilic antibiotic using poly(lactide-co-glycolide)-based electrospun nanofibrous scaffolds. J Control Release 2004; 98: 47-56.
25. Dong B, Arnoult O, Smith ME, et al. Electrospinning of collagen nanofiber scaffolds from benign solvents. Macromol Rapid Commun 2009; 30: 539-42.
26. Dong B, Arnoult O, Wnek G, Meng L. Benign solvents for forming protein structures. WO 2010/039890 A1, 2010.
27. Choi SH, Youn DY, Jo SM, et al. Micelle-mediated synthesis of single-crystalline beta(3C)-SiC fibers via emulsion electrospinning. ACS Appl Mater Interfaces 2011; 3:1385-9.
28. Zhang JF, Yang DZ, Xu F, et al. Electrospun Core-Shell Structure Nanofibers from Homogeneous Solution of Poly(ethylene oxide)/ Chitosan. Macromolecules 2009; 42: 5278-84.
29. Maretschek S, Greiner A, Kissel T. Electrospun biodegradable nanofiber nonwovens for controlled release of proteins. J Control Release 2008; 127: 180-7.
30. Yan S, Xiaoqiang L, Shuiping L, et al. Controlled release of dual drugs from emulsion electrospun nanofibrous mats. Colloids Surf B Biointerfaces 2009; 73: 376-81.
31. Zhang YZ, Wang X, Feng Y, et al. Coaxial electrospinning of (fluorescein isothiocyanate-conjugated bovine serum albumin)-encapsulated poly(epsilon-caprolactone) nanofibers for sustained release. Biomacromolecules 2006; 7: 1049-57.
32. Jiang H, Hu Y, Li Y, et al. A facile technique to prepare biodegradable coaxial electrospun nanofibers for controlled release of bioactive agents. J Control Release 2005; 108: 237-43.
33. Chakraborty S, Liao IC, Adler A, et al. Electrohydrodynamics: A facile technique to fabricate drug delivery systems. Adv Drug Deliv Rev 2009; 61: 1043-54.
34. Liao IC, Leong KW. Efficacy of engineered FVIII-producing skeletal muscle enhanced by growth factor-releasing co-axial electrospun fibers. Biomaterials 2011; 32: 1669-77.
35. Liao I, Leong K, Chew S-YS. Coaxial electrospun fibers and structures and methods of forming the same. US 2010/0055154 A1, 2010.
36. He W, Ma Z, Yong T, et al. Fabrication of collagen-coated biodegradable polymer nanofiber mesh and its potential for endothelial cells growth. Biomaterials 2005; 26: 7606-15.
37. Zhu Y, Leong MF, Ong WF, et al. Esophageal epithelium regeneration on fibronectin grafted poly(L-lactide-co-caprolactone) (PLLC) nanofiber scaffold. Biomaterials 2007; 28: 861-8.
38. Choi JS, Yoo HS, Electrospun nanofibers surface-modified with fluorescent proteins. J Bioact Compat Polym 2007; 22: 508-524.
39. Choi JS, Leong KW, Yoo HS, In vivo wound healing of diabetic ulcers using electrospun nanofibers immobilized with human epidermal growth factor (EGF). Biomaterials 2008; 29: 587-96.
40. Lee J, Yoo JJ, Atala A, et al. Controlled heparin conjugation on electrospun polycaprolactone/gelatin fibers for morphologydependent protein delivery and enhanced cellular affinity. Acta Biomater; in press.
41. Chung YI, Kim SK, Lee YK, et al. Efficient revascularization by VEGF administration via heparin-functionalized nanoparticle-fibrin complex. J Control Release 2010; 143: 282-9.
42. Guan R, Sun XL, Hou S, et al. A glycopolymer chaperone for fibroblast growth factor-2. Bioconjug Chem 2004; 15: 145-51.
43. Lyon M, Rushton G, Gallagher JT. The interaction of the transforming growth factor-betas with heparin/heparan sulfate is isoform-specific. J Biol Chem 1997; 272: 18000-6.
44. Sun B, Chen B, Zhao Y, et al. Crosslinking heparin to collagen scaffolds for the delivery of human platelet-derived growth factor. J Biomed Mater Res B Appl Biomater 2009; 91: 366-72.
45. Xu W, Yoo JJ, Atala A, et al., Controlled protein delivery through electrospun fibrous scaffolds for tissue engineering applications. Biomed Mater; in press.
46. Okuda T, Tominaga K, Kidoaki S. Time-programmed dual release formulation by multilayered drug-loaded nanofiber meshes. J Control Release 2010; 143: 258-64.
47. Shastri V, Sy J. Modulation of drug release rate from electrospun fibers. US 2008/0220054 A1, 2008.
48. Fujimoto K, Tobita K, Guan J, Wagner W, Keller B. Biodegradable elastomeric patch for treating cardiac or cardiovascular conditions. US 2008/0009830 A1, 2008.
49. Buevich F, Moses A, Do F, McJames W, Edelman W, Diamond M. Resorbable pouches for implantable medical devices. WO 2008/ 136856 A2, 2008.
50. Basu S, Chan G. Methods and compositions for treating post-cardial infarction damage. US 2008/0125745 A1, 2008.
51. Lee P, Li Y. Supramacrqmolecular polymer complexes providing controlled nitric oxide release for healing wounds. WO 2009/ 026680 A1, 2009.
52. Nagarajan R, Drew C, Mello C. Polymer-micelle complex as an aid to electrospinning. US 2009/0081457 A1, 2009.
53. Kuhn J, Zussman E. Encapsulation of bacteria and viruses in electrospun fibers. US 2009/0061496 A1, 2009.
54. Reneker D, Wu S, Wang P, Jia H, Narayanan R. Nanofibers with high enzyme loading for highly sensitive biosensors. WO 2009/029180 A1, 2009.
55. Van R, De Jager Heunis T, Dicks L, Botes M, De K. A product for delivering antimicrobially active substances to an infected site. WO 2011/045764 A1, 2011.
56. Reneker D, Smith D. Polymer no donor predrug nanofiber coating for medical devices and therapy. US 2008/0286321 A1, 2008.
57. Fattori R, Piva T. Drug-eluting stents in vascular intervention. Lancet 2003; 361: 247-9.
58. Smith D, Lopez M. Ethambutol based nitric oxide donors. US 2009/0069449 A1, 2009.
59. Shalaby S. Micromantled drug-eluting stent. US 2008/0241352 A1, 2008.
60. Reneker D, Smith D, Kataphinan W. Stent for use in cardiac, cranial, and other arteries. US 2008/0027531 A1, 2008.
61. Stankus J, Hossainy S, Wan J. Nanoparticle loaded electrospun implants or coatings for drug release. US 2011/0009949 A1, 2011.
62. Freund R. Drug eluting breast implant cover or coating. US 2011/0082545 A1, 2011.
63. Weber J, Miller M. Medical devices with drug-eluting coating. WO 2008/033711 A3R4, 2008.
64. Wang H. Innovative bottom-up cell assembly approach to threedimensional tissue formation using nano-or micro-fibers. US 2008/0112998 A1, 2008.
65. Atala A, Yoo JJ, Lim G, Czerw R, Soker S, Stitzel J. Cell scaffold matrices with incorporated therapeutic agents. US2006/0204441, 2006.